RTW Biotech Opportunities (LON:RTW – Get Free Report) shares shot up 0.5% during trading on Tuesday . The stock traded as high as GBX 2.21 and last traded at GBX 2.20. 290,412 shares changed hands during mid-day trading, a decline of 68% from the average session volume of 903,917 shares. The stock had previously closed at GBX 2.19.
RTW Biotech Opportunities Stock Performance
The firm has a market capitalization of £7.13 million, a P/E ratio of 0.03 and a beta of 1.15. The firm’s 50-day moving average is GBX 2.12 and its 200 day moving average is GBX 2.09.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Featured Stories
- Five stocks we like better than RTW Biotech Opportunities
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
